Natural products showcase the incredible diversity of evolution, serving as vital sources of medicinal compounds for centuries. From antibiotics to anticancer agents, these substances have played a crucial role in healthcare, especially since the discovery of penicillin. Despite advancements in biotechnology and genetic engineering, the significance of natural products remains strong, as they continue to inspire medicinal chemists in their quest to create innovative treatments. The exploration of these natural wonders promises to unveil countless undiscovered compounds with therapeutic potential.
Focusing on industrial pharmaceutical research, this book addresses a significant gap in existing literature, authored by international experts in the field. It encompasses essential pharmaceutical interests, including drug delivery, targeting, quality and safety management, approval and regulation, patenting, and biotechnology fundamentals. The first section provides a comprehensive review of the expanding range of biopharmaceuticals derived from modern molecular biological techniques. An additional section highlights critical patenting and drug regulation issues. The work concludes with detailed monographs on biotechnologically developed drugs currently available in the market.
With a foreword by Robert Langer, a distinguished professor at MIT and recipient of the prestigious Charles Stark Draper Prize, the book aims to present a balanced perspective on the biotechnological industry. The contributions from various industry experts enrich the content, offering valuable insights. Each chapter delivers an up-to-date review of key topics in pharmaceutical biotechnology, making this work an essential resource not only for industrial experts but also for pharmacists and scientists in related fields interested in biotech drugs.
